Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Application & Technology
3.2. Snippet by Products and Services
3.3. Snippet by End-User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Adoption of Genomics in Pharmaceutical Developments
4.1.1.2. Increasing Demand for Genomic Testing and Analysis
4.1.2. Restraints
4.1.2.1. Stringent Regulatory Challenges
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine Conflict Analysis
5.6. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Application & Technology
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application & Technology
7.1.2. Market Attractiveness Index, By Application & Technology
7.2. Functional Genomics *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.2.3. Transfection
7.2.4. Real-Time PCR
7.2.5. RNA Interference
7.2.6. Mutational Analysis
7.2.7. SNP Analysis
7.2.8. Microarray Analysis
7.3. Epigenomics
7.3.1. Bisulfite Sequencing
7.3.2. Chromatin Immunoprecipitation (CHIP & CHIP-Seq)
7.3.3. Methylated DNA Immunoprecipitation (MEDIP)
7.3.4. High-Resolution Melt (HRM)
7.3.5. Chromatin Accessibility Assays
7.3.6. Microarray Analysis
7.4. Pathway Analysis
7.4.1. Bead-Based Analysis
7.4.2. Microarray Analysis
7.4.3. Real-Time PCR
7.4.4. Proteomics Tools
7.5. Biomarker Discovery
7.5.1. Mass Spectrometry
7.5.2. Real-Time PCR
7.5.3. Microarray Analysis
7.5.4. Statistical Analysis
7.5.5. Bioinformatics
7.5.6. DNA Sequencing
7.6. Others
8. By Products and Services
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Products and Services
8.1.2. Market Attractiveness Index, By Products and Services
8.2. Products *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.2.3. Instruments/Systems/Software
8.2.4. Consumables & Reagents
8.3. Services
8.3.1. NGS-Based Services
8.3.2. Introduction
8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.4. Core Genomics Services
8.5. Biomarker Translation Services
8.6. Computational Services
8.7. Others
9. By End-User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Clinical Research
9.3. Academic & Government Institutes
9.3.1. Introduction
9.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.4. Hospitals & Clinics
9.5. Pharmaceutical & Biotechnology Companies
9.6. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application & Technology
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Products and Services
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application & Technology
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Products and Services
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Russia
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application & Technology
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Products and Services
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application & Technology
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Products and Services
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application & Technology
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Products and Services
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Agilent Technologies *
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Bio-Rad Laboratories, Inc.
12.3. BGI Genomics
12.4. Color Genomics, Inc
12.5. Danaher Corporation
12.6. Eurofins Scientific
12.7. F. Hoffmann-La Roche Ltd
12.8. GE Healthcare
12.9. Illumina, Inc.
12.10. Myriad Genetics, Inc.
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us